Comments
Loading...

Inhibikase Therapeutics Stock Guidance

IKTNASDAQ
Logo brought to you by Benzinga Data
$2.12
-0.11-4.93%
At close: -
$2.12
0.000.00%
After Hours: 6:46 PM EDT
Q1 2025 Earnings were released on Wed May 14th, after the market close

Inhibikase Therapeutics Stock Guidance | NASDAQ:IKT | Benzinga

Inhibikase Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
Inhibikase Therapeutics Inc (IKT) does not provide guidance data

FAQ

Q

What is the most recent guidance for Inhibikase Therapeutics (IKT)?

A

There have been no specific sales or earnings guidance reported for Inhibikase Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch